
Urban Edge Properties
Real Estate
Urban Edge Properties (UE) Stock News
The latest UE headlines and market coverage — 16 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
INNSUITES FY 2027 Q1 RECORDS CONSOLIDATED NET INCOME PROFIT; REVERSE MERGER EXPLORATION CONTINUES
InnSuites Hospitality Trust (IHT) reported Fiscal Q1 2027 net income of $74,702, a $35,672 improvement year-over-year, with record hotel revenue of $2.2 million and combined occupancy reaching 85.37%. The company continues exploring diversification opportunities including a potential reverse merger, IBC Hotels independent hotel services, and investments in UniGen Power's clean energy technology.
- GlobeNewswire Inc.·
BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk
BioAge Labs announced the first participant has been dosed in QUELL-CV, a Phase 2 proof-of-concept trial evaluating BGE-102, an oral NLRP3 inhibitor for cardiovascular risk reduction. The randomized, double-blind, placebo-controlled trial will enroll approximately 160 participants with obesity and elevated inflammation across three dose levels. Phase 1 results showed BGE-102 achieved median hsCRP reductions of 86% and was well tolerated. Topline data are anticipated in the second half of 2026, with an additional Phase 1b/2a trial in diabetic macular edema planned for mid-2026.
- Benzinga·
GROUPE DYNAMITE POSTS 37% REVENUE GROWTH AND 4-YEAR HIGH GROSS MARGIN IN Q1 2026
Delivered strong Q1 2026 comparable store sales growth 1 of 22.6% and total revenue growth of 37.0% Achieved a four-year high gross margin 1 of 67.4 %, an increase of 530 bps Expanded adjusted EBITDA margin 1 to 36.8 %, underscoring our luxury-inspired business model Continued successful expansion with new stores outperforming expectations Raised adjusted EBITDA margin guidance for Fiscal 2026 to 38.25%–39.50 % MONTRÉAL , June 16, 2026 /CNW/ - Groupe Dynamite Inc. ("Groupe Dynamite" or the "Company") (TSX: GRGD ) today reported its financial results for the fiscal year 2026's first quarter ended May 2, 2026. "Our first quarter results demonstrate the strength of our operating model and our ability to deliver profitable growth. Comparable store sales increased 22.6%, gross margin reached a four-year high, and adjusted EBITDA margin expanded to 36.8% of revenue, positioning ourselves alongside the world's most profitable fashion houses. We continue to strive to remain a highly productive specialty retailer with strong brands, exceptional unit economics, disciplined inventory management, attractive returns on capital, and a growth engine we have built over decades that continues to scale profitably," said Andrew Lutfy, Chief Executive Officer and Chair of the Board. "Q1 was a strong start to fiscal 2026. Across both GARAGE and DYNAMITE, customers responded positively to our assortments, marketing campaigns and the consistency of the experience we deliver across channels. Our real estate strategy continues to be a significant driver of growth, customer acquisition and profitability. By opening new locations in premium centers, optimizing our fleet and delivering a compelling in-store experience, we continue to drive significant productivity improvements across our store network. Most importantly, we continue to see strong customer engagement across both brands, reflected
- Benzinga·
EDWARD SMOLYANSKY, KEY LWAY SHAREHOLDER: TERMINATION OF POISON PILL MARKS IMPORTANT INFLECTION POINT FOR LIFEWAY SHAREHOLDERS AS GOVERNANCE QUESTIONS MOUNT AHEAD OF THE ELECTION
Edward Smolyansky, largest shareholder and former COO of Lifeway Foods, criticizes the Board's governance, stating the poison pill was only terminated after ISS recommended voting against all directors. He highlights a pattern of reactive governance, the reversal of a board refresh process, and calls for shareholders to vote against incumbent directors at the June 17 Annual Meeting to register dissatisfaction with the Board's conduct.
- Benzinga·
VINFAST'S GLOBAL REVENUE IN Q1 2026 INCREASED 42% YEAR OVER YEAR
SINGAPORE , June 8, 2026 /PRNewswire/ -- VinFast Auto Ltd. announced its unaudited financial results for the first quarter ended March 31, 2026. In the first quarter of 2026, VinFast ("the Company") delivered 58,577 electric vehicles, representing an increase of 61% from the same period last year. International markets accounted for approximately 8% of total deliveries during the quarter. In Vietnam, VinFast's EV deliveries in the first quarter of 2026 increased by 53% year over year. The Company maintained its position as the number one OEM in the domestic automotive market since September 2024. Southeast Asia and India continue to be key growth markets for VinFast. At the end of the first quarter of 2026, VinFast ranked #1 BEV brand in the Philippines, #4 in India and #8 in Indonesia. The Company also delivered 143,136 units of e-scooters and e-bikes in the first quarter, representing an increase of 219% from the first quarter of 2025. In March alone, VinFast received more than 135,000 e-scooter orders and shipped over 93,000 e-scooters to dealers in Vietnam. VinFast currently holds the leading position in Vietnam's electric motorcycle market and, in March, expanded its share of the overall motorcycle market (including both ... Full story available on Benzinga.com
- Benzinga·
VERSABANK REPORTS STRONG SECOND QUARTER RESULTS: STRONG US SRP GROWTH DRIVES 27% YEAR-OVER-YEAR INCREASE IN REVENUE AND NET INTEREST INCOME, 45% YEAR-OVER-YEAR GROWTH IN ADJUSTED (CORE) NET INCOME
All amounts are unaudited and in Canadian dollars and are based on financial statements prepared in compliance with International Accounting Standard 34 Interim Financial Reporting, unless otherwise noted. Our second quarter 2026 ("Q2 2026") unaudited Interim Consolidated Financial Statements for the period ended April 30, 2026 and Management's Discussion and Analysis ("MD&A"), are available online at www.versabank.com/investor-relations , SEDAR at www.sedarplus.ca and EDGAR at www.sec.gov/edgar . Supplementary Financial Information will also be available on our website at www.versabank.com/investor-relations . LONDON, ON , June 3, 2026 /CNW/ - VersaBank (or the "Bank") (TSX: VBNK (NASDAQ: VBNK ), a North American leader in business-to-business digital banking, as well as technology solutions for cybersecurity, today reported its results for the second quarter ended April 30, 2026. All figures are in Canadian dollars unless otherwise stated. NOTE REGARDING SECOND QUARTER FISCAL 2026 FINANCIAL RESULTS VersaBank's financial results for the second quarter of fiscal 2026 reflect non-core non-interest expenses in the amount of $6.7 million. The non-core non-interest expenses included $4.5 million related to the project costs associated with the Reorganization (see Reorganization note below). Subsequent to the end of the second quarter, the Bank publicly filed a Form S-4 registration statement (the "Registration Statement") with the U.S. Securities and Exchange Commission (the "SEC") in connection with the Reorganization. The Reorganization is intended to enhance shareholder value, mitigate risk and reduce corporate costs over the long term. The Bank expects that the anticipated benefits of the Reorganization will exceed the associated investment however, these expected benefits are subject to various assumptions and uncertainties. As of the end of the second quarter of
- GlobeNewswire Inc.·
SIKA ERNENNT NEUES MITGLIED DER KONZERNLEITUNG UND TREIBT DIGITALE TRANSFORMATION VORAN
Sika has appointed Philipp Irniger as Head Construction and member of the executive board effective June 1, 2026, succeeding Ivo Schädler who retires after 30+ years. The company also created a new Chief Digital & Information Officer position, with Jochen Werling taking the role to accelerate digital transformation and the Fast-Forward program.
- Benzinga·
DR. PHONE FIX REPORTS RECORD Q1 2026 RESULTS AND CONTINUED NATIONAL EXPANSION MOMENTUM
Q1 Revenue Up 44% YoY; Same-Store Sales Up 29%; Adjusted EBITDA Turns Positive as Company Advances National Expansion Strategy EDMONTON, AB , June 1, 2026 /CNW/ - Dr. Phone Fix Canada Corporation (TSXV: DPF) ("Dr. Phone Fix" or the "Company"), one of Canada's fastest-growing and award-winning consumer electronics repair and resale platforms, today reported financial results for the three months ended March 31, 2026, and provided an update on recent corporate developments. The Company operates a network of 44 corporately owned stores across five Canadian provinces. Financial Results Summary (CAD) (all dollar amounts in 000's) Three Months Ended Mar 31, 2026 Three Months Ended Mar 31, 2025 Variance (%) Revenue 3,162 2,196 +44 % Gross Profit 1,621 1,210 +34 % Gross Margin 51.3 % 55.1 % -3.8 pp Operating Expenses (SG&A) 2,476 1,754 +41 % Adjusted EBITDA(1) 88 (13) n/m Cash 291 1,558 -81 % (1) See Non-GAAP Financial Measure towards the end of this document. "Q1 reflected continued progress in the execution of our strategy with revenue increasing 44% year-over-year and comparable-store sales increasing 29%, even in what is typically our seasonally weakest quarter," said Piyush Sawhney, Founder and Chief Executive Officer of Dr. Phone Fix. "We also delivered positive Adjusted EBITDA, generated positive operating cash flow, and continued to improve execution across our national network while integrating recently acquired locations and advancing our OEM, insurance, supplier, repair and certified pre-owned device programs." Mr. Sawhney continued, "We have spent the past year building the foundation for a national, carrier-neutral device lifecycle platform. Today, we have 44 corporately owned locations across five provinces, a growing pipeline of acquisition and greenfield opportunities, and a strategy focused on disciplined expansion and stronger unit-level economics throug
- Benzinga·
FLUENT Reports First Quarter 2026 Results
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="center"><em>Q1 2026 Revenue of $17.9M</em><br /><em>Ended quarter with $8.3 million of cash and cash equivalents</em><br /><em>Received net proceeds of $5.7 million from interim financing</em><br /><em>Continued progress on Vireo transaction and Texas divestiture</em></p> <p align="justify">TAMPA, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=dUAxyqckkUEdHWQlOcVBLierqtd2OYNadN_XBkggQSzWyBH8-ifdpW-9Teq8SbFZv21n1pHjtZ7p7bslwNuu2g==" rel="nofollow" target="_blank" rel="nofollow"><u>FLUENT Corp.</u></a> (CSE:<a class="ticker" href="https://www.benzinga.com/quote/FNT" rel="nofollow">FNT</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/quote/CNTMF" rel="nofollow">CNTMF</a>) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced its financial and operating results for the first quarter ended March 31, 2026. Unless otherwise indicated, all financial results are presented in U.S. dollars.</p> <p align="justify"><strong>Management Commentary</strong><br />Cost reduction across the base business remained a top priority for the leadership team during Q1 2026, resulting in a year-over-year reduction of more than 20% in total operating expenses.</p> <p align="justify">"The Company remained focused on key strategic priorities in the quarter, including cost reductions, operational efficiencies, and broader b
- Benzinga·
MEDX HOLDINGS (MEDH) REPORTS EXCEPTIONAL Q1 2026 FINANCIALS: REVENUE SURGES, EXPANSION ON TRACK, AND CEO TO SPEAK AT HEMP BEVERAGE EXPO
Austin, Texas , May 26, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MEDX HOLDINGS (MEDH) REPORTS EXCEPTIONAL Q1 2026 FINANCIALS: REVENUE SURGES, EXPANSION ON TRACK, AND CEO TO SPEAK AT HEMP BEVERAGE EXPO AUSTIN, Texas — May 26, 2026 — MedX Holdings, Inc. (OTC: MEDH ) (soon to be Dazed Inc., pending ticker symbol DAZE), a dynamic brands and acquisition company focused on the emerging hemp, cannabis, and hospitality industries, today announced its financial results for the first quarter ended March 31, 2026. The company is thrilled to report significant year-over-year revenue and gross profit growth, continued profitability, and major traction in its nationwide franchise expansion. Q1 2026 Financial Highlights: Accelerated Growth and Profitability The first quarter of 2026 reflects the power of MedX's strategic focus on high-margin branding, efficient operations, and calculated expansion. Key financial milestones from the Q1 2026 consolidated financial statements include: Solid Revenue Growth: Q1 2026 revenues reached $521,874, representing an impressive 52.7% increase compared to revenues of $341,711 in Q1 2025. Surging Gross Profit: Gross profit for the quarter climbed to $398,990, a 70.6% jump from the $233,793 reported in the same period last year. Sustained Profitability: The company maintained a positive bottom line, reporting a net income of $22,203 for the three months ended March 31, 2026. Expansion on Track: Bringing the "Third Place" to New Cities Following the momentum built in late 2025, ... Full story available on Benzinga.com
- Benzinga·
LSL PHARMA GROUP REPORTS RECORD REVENUES AND FIRST QUARTER 2026 RESULTS
LSL Pharma Group Reports Record Q1-2026 Revenues while positioning for improved profitability following Steri-Med Pharma production resumption. Launch of new eye-drop portfolio planned for the second quarter of 2026. Secured US-FDA certification of Steri-Med to manufacture ophthalmic ointment for the US market. BOUCHERVILLE, QC , May 25, 2026 /CNW/ - LSL PHARMA GROUP INC . (TSXV: LSL ) (the " Corporation " or " LSL Pharma "), a Canadian integrated pharmaceutical company, today reported its financial results for the first quarter ended March 31, 2026 ("Q1-26"). All amounts are presented in millions ("M") of Canadian dollars. Q1-26 Corporate and Financial Highlights Record quarterly consolidated revenues, including full quarter contribution from Laboratoire Du-Var ("Du-Var") and Juno OTC acquired on January 1 st , 2026 and to be presented as 3 rd business segment; Strong Eye-Care revenues show significant market share gains in Canada; Q1-26 profitability temporarily impacted by the three-month Steri-Med Pharma (Steri-Med) production pause, with full production activities having resumed in April 2026; Secured US-FDA certification of Steri-Med to manufacture ophthalmic ointment for the US market; Commissioning of new state-of-the-art sterile ointment manufacturing line on track for commercial production by Q1-27; Development of three (3) new ointment products initiated for regulatory filings during FY-27. Binding term sheet signed with Instapill Private Limited ("Instapill") for the Canadian rights to private label Loratadine 10 mg Orally Disintegrating Tablets (ODT), a bioequivalent product to Claritin® Rapid Dissolve TM ; Revolving credit facility increased from $7.5M to $11M; "During the first quarter of 2026, we saw the positive impact of the recent acquisitions of Juno OTC and Du-Var on our operating results and the diversification of our business platform. Whil
- GlobeNewswire Inc.·
FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND
Flyte, a regional air mobility company, announced full-scale activation of its Memorial Day flight network across the Northeast corridor, deploying aircraft on high-frequency short-haul routes including NYC to Nantucket, Hamptons, and Martha's Vineyard. The company aims to capture premium travel demand during the holiday weekend surge by offering sub-one-hour flights as an alternative to congested ground travel.
- GlobeNewswire Inc.·Neutral
Bitget Launches UEX Jumpstart Program With 430K USDT Rewards
Bitget, the world's largest Universal Exchange, has launched the UEX Jumpstart Program, a multi-product onboarding initiative with a 430,000 USDT prize pool spanning crypto futures, precious metals, stocks, and CFDs. The program runs through June 2026 and reflects growing market diversification, with non-crypto assets accounting for 40% of Bitget's Q1 2026 trading volume.
- Benzinga·
TURBO ENERGY FILES FY2025 ANNUAL REPORT HIGHLIGHTING 107% REVENUE GROWTH AND STRATEGIC TRANSITION TO AI-DRIVEN ENERGY INFRASTRUCTURE
VALENCIA, Spain, May 18, 2026 (GLOBE NEWSWIRE) -- Turbo Energy, S.A. (NASDAQ: TURB ) ("Turbo Energy" or the "Company"), a global integrator of AI-driven solar energy storage solutions and intelligent energy management systems, today announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission ("SEC"). Turbo Energy reported full year 2025 revenue of $23.46 million, representing year-over-year growth of 107% compared to 2024. The Company also reported a significant improvement in operating performance, with operating loss decreasing to $0.91 million compared to $4.11 million in the prior year, while net loss decreased to $1.36 million compared to $3.45 million in 2024. During early 2026, Turbo Energy further strengthened its financial position through approximately $5.0 million in aggregate gross proceeds raised through a Registered Direct Offering ("RDO") and issuances under its "at-the-market" ("ATM") program. These transactions significantly reinforced the Company's balance sheet and increased shareholders' equity by approximately $4.6 million, from approximately $1.88 million¹ in 2025 to approximately $6.48 million in 2026, positioning the Company well above Nasdaq's minimum stockholders' equity requirement for continued listing. 2025 marked a decisive operational and strategic inflection point for Turbo Energy, as the Company accelerated its transition from a traditional energy storage provider into an AI-driven intelligent energy infrastructure platform focused on software-defined energy management, advanced storage integration and high-value commercial and industrial ("C&I") deployments. Throughout 2025, Turbo Energy continued expanding its positioning as a technology integrator capable of combining solar generation, advanced battery storage and propriet
- GlobeNewswire Inc.·
NANOBIOTIX ANNONCE LA PRÉSENTATION DE DONNÉES DE LA PREMIÉRE PARTIE DE L’ÉTUDE CLINIQUE RANDOMISÉE DE PHASE 2 EVALUANT JNJ-1900 (NBTXR3) DANS LES CANCERS DU POUMON DE STADE 3 INOPÉRABLE
Nanobiotix announced early results from the Phase 2 CONVERGE study evaluating JNJ-1900 (NBTXR3), a nanoradioenhancer developed in collaboration with Johnson & Johnson, in patients with stage 3 inoperable non-small cell lung cancer. The study showed promising efficacy with an 85.7% overall response rate and 57.1% complete response rate in 7 patients who completed treatment, compared to less than 5% complete response rates with current standard of care.
- The Motley Fool·
UEIC Q1 2026 Earnings Transcript
Universal Electronics Inc. reported Q1 2026 revenue of $79 million, down 14.4% year-over-year, with declines in both home entertainment and connected home segments due to market headwinds and extended deployment timelines. Despite lower revenue, the company improved its adjusted non-GAAP net loss to $1.3 million through cost reduction initiatives, including $5 million in annualized labor savings. Management reaffirmed full-year adjusted non-GAAP diluted EPS guidance of $0.45-$0.65, up from $0.31 in 2025, focusing on cost discipline and working capital management rather than near-term demand recovery.